Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 248 entries
Sorted by: Best Match Show Resources per page
Volatile constituents of Dietes bicolor (Iridaceae) and their antimicrobial activity.

Zeitschrift fur Naturforschung. C, Journal of biosciences

Ayoub IM, Youssef FS, El-Shazly M, Ashour ML, Singab AN, Wink M.
PMID: 26368045
Z Naturforsch C J Biosci. 2015 Jul 01;70(7):217-25. doi: 10.1515/znc-2015-0164.

Volatile oils from the leaves, flowers and rhizomes of Dietes bicolor (Steud.) Sweet ex Klatt (Iridaceae) were analyzed using GLC/FID and GLC/MS. A total of 84 compounds were identified accounting for 94.65, 95.63 and 87.09% in the hydrodistilled oils...

Cite
Ayoub IM, Youssef FS, El-Shazly M, et al. Volatile constituents of Dietes bicolor (Iridaceae) and their antimicrobial activity. Z Naturforsch C J Biosci. 2015;70(7):217-25doi: 10.1515/znc-2015-0164.
Ayoub, I. M., Youssef, F. S., El-Shazly, M., Ashour, M. L., Singab, A. N., & Wink, M. (2015). Volatile constituents of Dietes bicolor (Iridaceae) and their antimicrobial activity. Zeitschrift fur Naturforschung. C, Journal of biosciences, 70(7), 217-25. https://doi.org/10.1515/znc-2015-0164
Ayoub, Iriny M, et al. "Volatile constituents of Dietes bicolor (Iridaceae) and their antimicrobial activity." Zeitschrift fur Naturforschung. C, Journal of biosciences vol. 70,7 (2015): 217-25. doi: https://doi.org/10.1515/znc-2015-0164
Ayoub IM, Youssef FS, El-Shazly M, Ashour ML, Singab AN, Wink M. Volatile constituents of Dietes bicolor (Iridaceae) and their antimicrobial activity. Z Naturforsch C J Biosci. 2015 Jul 01;70(7):217-25. doi: 10.1515/znc-2015-0164. PMID: 26368045.
Copy Download .nbib Format: NLM
Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease.

Journal of clinical and translational hepatology

Borai IH, Shaker Y, Kamal MM, Ezzat WM, Ashour E, Afify M, Gouda W, Elbrashy MM.
PMID: 28660148
J Clin Transl Hepatol. 2017 Jun 28;5(2):109-118. doi: 10.14218/JCTH.2017.00004. Epub 2017 Jun 07.

No abstract available.

Cite
Borai IH, Shaker Y, Kamal MM, et al. Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol. 2017;5(2):109-118doi: 10.14218/JCTH.2017.00004.
Borai, I. H., Shaker, Y., Kamal, M. M., Ezzat, W. M., Ashour, E., Afify, M., Gouda, W., & Elbrashy, M. M. (2017). Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease. Journal of clinical and translational hepatology, 5(2), 109-118. https://doi.org/10.14218/JCTH.2017.00004
Borai, Ibrahim H, et al. "Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease." Journal of clinical and translational hepatology vol. 5,2 (2017): 109-118. doi: https://doi.org/10.14218/JCTH.2017.00004
Borai IH, Shaker Y, Kamal MM, Ezzat WM, Ashour E, Afify M, Gouda W, Elbrashy MM. Evaluation of Biomarkers in Egyptian Patients with Different Grades of Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol. 2017 Jun 28;5(2):109-118. doi: 10.14218/JCTH.2017.00004. Epub 2017 Jun 07. PMID: 28660148; PMCID: PMC5472931.
Copy Download .nbib Format: NLM
Studies on the Red Sea Sponge Haliclona sp. for its Chemical and Cytotoxic Properties.

Pharmacognosy magazine

Al-Massarani SM, El-Gamal AA, Al-Said MS, Abdel-Kader MS, Ashour AE, Kumar A, Abdel-Mageed WM, Al-Rehaily AJ, Ghabbour HA, Fun HK.
PMID: 27076747
Pharmacogn Mag. 2016 Apr-Jun;12(46):114-9. doi: 10.4103/0973-1296.177906.

BACKGROUND: A great number of novel compounds with rich chemical diversity and significant bioactivity have been reported from Red Sea sponges.OBJECTIVE: To isolate, identify, and evaluate the cytotoxic activity of the chemical constituents of a sponge belonging to genus...

Cite
Al-Massarani SM, El-Gamal AA, Al-Said MS, et al. Studies on the Red Sea Sponge Haliclona sp. for its Chemical and Cytotoxic Properties. Pharmacogn Mag. 2016;12(46):114-9doi: 10.4103/0973-1296.177906.
Al-Massarani, S. M., El-Gamal, A. A., Al-Said, M. S., Abdel-Kader, M. S., Ashour, A. E., Kumar, A., Abdel-Mageed, W. M., Al-Rehaily, A. J., Ghabbour, H. A., & Fun, H. K. (2016). Studies on the Red Sea Sponge Haliclona sp. for its Chemical and Cytotoxic Properties. Pharmacognosy magazine, 12(46), 114-9. https://doi.org/10.4103/0973-1296.177906
Al-Massarani, Shaza Mohamed, et al. "Studies on the Red Sea Sponge Haliclona sp. for its Chemical and Cytotoxic Properties." Pharmacognosy magazine vol. 12,46 (2016): 114-9. doi: https://doi.org/10.4103/0973-1296.177906
Al-Massarani SM, El-Gamal AA, Al-Said MS, Abdel-Kader MS, Ashour AE, Kumar A, Abdel-Mageed WM, Al-Rehaily AJ, Ghabbour HA, Fun HK. Studies on the Red Sea Sponge Haliclona sp. for its Chemical and Cytotoxic Properties. Pharmacogn Mag. 2016 Apr-Jun;12(46):114-9. doi: 10.4103/0973-1296.177906. PMID: 27076747; PMCID: PMC4809165.
Copy Download .nbib Format: NLM
Coping strategies in egyptian ladies with breast cancer.

Breast cancer : basic and clinical research

Elsheshtawy EA, Abo-Elez WF, Ashour HS, Farouk O, El Zaafarany MI.
PMID: 24940070
Breast Cancer (Auckl). 2014 Jun 05;8:97-102. doi: 10.4137/BCBCR.S14755. eCollection 2014.

INTRODUCTION: A diagnosis of breast cancer regardless of the stage can be stressful, impact multiple spheres of life, and disrupt physical status, emotional and spiritual well-being, and personal relationships for the patient and family. In order to adapt, the...

Cite
Elsheshtawy EA, Abo-Elez WF, Ashour HS, et al. Coping strategies in egyptian ladies with breast cancer. Breast Cancer (Auckl). 2014;8:97-102doi: 10.4137/BCBCR.S14755.
Elsheshtawy, E. A., Abo-Elez, W. F., Ashour, H. S., Farouk, O., & El Zaafarany, M. I. (2014). Coping strategies in egyptian ladies with breast cancer. Breast cancer : basic and clinical research, 897-102. https://doi.org/10.4137/BCBCR.S14755
Elsheshtawy, Eman A, et al. "Coping strategies in egyptian ladies with breast cancer." Breast cancer : basic and clinical research vol. 8 (2014): 97-102. doi: https://doi.org/10.4137/BCBCR.S14755
Elsheshtawy EA, Abo-Elez WF, Ashour HS, Farouk O, El Zaafarany MI. Coping strategies in egyptian ladies with breast cancer. Breast Cancer (Auckl). 2014 Jun 05;8:97-102. doi: 10.4137/BCBCR.S14755. eCollection 2014. PMID: 24940070; PMCID: PMC4055407.
Copy Download .nbib Format: NLM
Illness perception in patients with coronary artery disease: A systematic review.

International journal of nursing practice

Al-Smadi AM, Ashour A, Hweidi I, Gharaibeh B, Fitzsimons D.
PMID: 27687787
Int J Nurs Pract. 2016 Dec;22(6):633-648. doi: 10.1111/ijn.12494. Epub 2016 Sep 29.

The aim of this study was to conduct a systematic review that investigates the differences in illness perception with age and gender in patients diagnosed with coronary artery disease. Previous studies show some discrepancies regarding the influence of age...

Cite
Al-Smadi AM, Ashour A, Hweidi I, et al. Illness perception in patients with coronary artery disease: A systematic review. Int J Nurs Pract. 2016;22(6):633-648doi: 10.1111/ijn.12494.
Al-Smadi, A. M., Ashour, A., Hweidi, I., Gharaibeh, B., & Fitzsimons, D. (2016). Illness perception in patients with coronary artery disease: A systematic review. International journal of nursing practice, 22(6), 633-648. https://doi.org/10.1111/ijn.12494
Al-Smadi, Ahmed Mohammad, et al. "Illness perception in patients with coronary artery disease: A systematic review." International journal of nursing practice vol. 22,6 (2016): 633-648. doi: https://doi.org/10.1111/ijn.12494
Al-Smadi AM, Ashour A, Hweidi I, Gharaibeh B, Fitzsimons D. Illness perception in patients with coronary artery disease: A systematic review. Int J Nurs Pract. 2016 Dec;22(6):633-648. doi: 10.1111/ijn.12494. Epub 2016 Sep 29. PMID: 27687787.
Copy Download .nbib Format: NLM
Hepatobiliary Schistosomiasis.

Journal of clinical and translational hepatology

Shaker Y, Samy N, Ashour E.
PMID: 26357627
J Clin Transl Hepatol. 2014 Sep;2(3):212-6. doi: 10.14218/JCTH.2014.00018. Epub 2014 Sep 15.

Schistosomiasis is an ancient parasitic disease that has afflicted Egyptians since the time of the pharaohs. The disease is caused by lodged schistosome eggs in the host liver, evoking an immune response and leading in some patients to the...

Cite
Shaker Y, Samy N, Ashour E. Hepatobiliary Schistosomiasis. J Clin Transl Hepatol. 2014;2(3):212-6doi: 10.14218/JCTH.2014.00018.
Shaker, Y., Samy, N., & Ashour, E. (2014). Hepatobiliary Schistosomiasis. Journal of clinical and translational hepatology, 2(3), 212-6. https://doi.org/10.14218/JCTH.2014.00018
Shaker, Yehia, et al. "Hepatobiliary Schistosomiasis." Journal of clinical and translational hepatology vol. 2,3 (2014): 212-6. doi: https://doi.org/10.14218/JCTH.2014.00018
Shaker Y, Samy N, Ashour E. Hepatobiliary Schistosomiasis. J Clin Transl Hepatol. 2014 Sep;2(3):212-6. doi: 10.14218/JCTH.2014.00018. Epub 2014 Sep 15. PMID: 26357627; PMCID: PMC4521248.
Copy Download .nbib Format: NLM
a-Si:H/SiNW shell/core for SiNW solar cell applications.

Nanoscale research letters

Ashour ES, Sulaiman MY, Ruslan MH, Sopian K.
PMID: 24195734
Nanoscale Res Lett. 2013 Nov 06;8(1):466. doi: 10.1186/1556-276X-8-466.

Vertically aligned silicon nanowires have been synthesized by the chemical etching of silicon wafers. The influence of a hydrogenated amorphous silicon (a-Si:H) layer (shell) on top of a silicon nanowire (SiNW) solar cell has been investigated. The optical properties...

Cite
Ashour ES, Sulaiman MY, Ruslan MH, et al. a-Si:H/SiNW shell/core for SiNW solar cell applications. Nanoscale Res Lett. 2013;8(1):466doi: 10.1186/1556-276X-8-466.
Ashour, E. S., Sulaiman, M. Y., Ruslan, M. H., & Sopian, K. (2013). a-Si:H/SiNW shell/core for SiNW solar cell applications. Nanoscale research letters, 8(1), 466. https://doi.org/10.1186/1556-276X-8-466
Ashour, Eman Sad, et al. "a-Si:H/SiNW shell/core for SiNW solar cell applications." Nanoscale research letters vol. 8,1 (2013): 466. doi: https://doi.org/10.1186/1556-276X-8-466
Ashour ES, Sulaiman MY, Ruslan MH, Sopian K. a-Si:H/SiNW shell/core for SiNW solar cell applications. Nanoscale Res Lett. 2013 Nov 06;8(1):466. doi: 10.1186/1556-276X-8-466. PMID: 24195734; PMCID: PMC3829805.
Copy Download .nbib Format: NLM
The influence of treatment modality on illness perception and secondary prevention outcomes among patients with acute myocardial infarction.

International journal of nursing sciences

Al-Smadi AM, Tawalbeh LI, Ashour A, Hweidi IM, Gharaibeh B, Slater P, Fitzsimons D.
PMID: 31406752
Int J Nurs Sci. 2017 Jun 23;4(3):271-277. doi: 10.1016/j.ijnss.2017.06.007. eCollection 2017 Jul 10.

OBJECTIVES: This study aims to determine if patients with acute myocardial infarction differ in illness perception and secondary prevention outcomes depending on the treatment they received.METHODS: A repeated measures design was used to compare patients with acute myocardial infarction...

Cite
Al-Smadi AM, Tawalbeh LI, Ashour A, et al. The influence of treatment modality on illness perception and secondary prevention outcomes among patients with acute myocardial infarction. Int J Nurs Sci. 2017;4(3):271-277doi: 10.1016/j.ijnss.2017.06.007.
Al-Smadi, A. M., Tawalbeh, L. I., Ashour, A., Hweidi, I. M., Gharaibeh, B., Slater, P., & Fitzsimons, D. (2017). The influence of treatment modality on illness perception and secondary prevention outcomes among patients with acute myocardial infarction. International journal of nursing sciences, 4(3), 271-277. https://doi.org/10.1016/j.ijnss.2017.06.007
Al-Smadi, Ahmed Mohammad, et al. "The influence of treatment modality on illness perception and secondary prevention outcomes among patients with acute myocardial infarction." International journal of nursing sciences vol. 4,3 (2017): 271-277. doi: https://doi.org/10.1016/j.ijnss.2017.06.007
Al-Smadi AM, Tawalbeh LI, Ashour A, Hweidi IM, Gharaibeh B, Slater P, Fitzsimons D. The influence of treatment modality on illness perception and secondary prevention outcomes among patients with acute myocardial infarction. Int J Nurs Sci. 2017 Jun 23;4(3):271-277. doi: 10.1016/j.ijnss.2017.06.007. eCollection 2017 Jul 10. PMID: 31406752; PMCID: PMC6626236.
Copy Download .nbib Format: NLM
Centroid tracking and velocity measurement of white blood cell in video.

Health information science and systems

Ata MM, Ashour AS, Guo Y, Elnaby MMA.
PMID: 30425827
Health Inf Sci Syst. 2018 Nov 01;6(1):20. doi: 10.1007/s13755-018-0060-2. eCollection 2018 Dec.

Automated blood cells tracking system has a vital role as the tracking process reflects the blood cell characteristics and indicates several diseases. Blood cells tracking is challenging due to the non-rigid shapes of the blood cells, and the variability...

Cite
Ata MM, Ashour AS, Guo Y, et al. Centroid tracking and velocity measurement of white blood cell in video. Health Inf Sci Syst. 2018;6(1):20doi: 10.1007/s13755-018-0060-2.
Ata, M. M., Ashour, A. S., Guo, Y., & Elnaby, M. M. A. (2018). Centroid tracking and velocity measurement of white blood cell in video. Health information science and systems, 6(1), 20. https://doi.org/10.1007/s13755-018-0060-2
Ata, Mohamed Maher, et al. "Centroid tracking and velocity measurement of white blood cell in video." Health information science and systems vol. 6,1 (2018): 20. doi: https://doi.org/10.1007/s13755-018-0060-2
Ata MM, Ashour AS, Guo Y, Elnaby MMA. Centroid tracking and velocity measurement of white blood cell in video. Health Inf Sci Syst. 2018 Nov 01;6(1):20. doi: 10.1007/s13755-018-0060-2. eCollection 2018 Dec. PMID: 30425827; PMCID: PMC6212371.
Copy Download .nbib Format: NLM
Dual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies.

Future science OA

El-Miligy MM, Rida SM, Ashour FA, Badr MH, El-Bassiony EM, El-Demellawy MA, Omar AM.
PMID: 29255624
Future Sci OA. 2017 Oct 25;4(1):FSO252. doi: 10.4155/fsoa-2017-0075. eCollection 2018 Jan.

AIM: Simultaneous inhibition of hepatitis C virus (HCV) and hepatocellular carcinoma (HCC) may enhance anti-HCV effects and reduce resistance and side effects.RESULTS/METHODOLOGY: Novel hybrid derivatives were designed and synthesized to exhibit dual activity against HCV and its associated major...

Cite
El-Miligy MM, Rida SM, Ashour FA, et al. Dual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies. Future Sci OA. 2017;4(1):FSO252doi: 10.4155/fsoa-2017-0075.
El-Miligy, M. M., Rida, S. M., Ashour, F. A., Badr, M. H., El-Bassiony, E. M., El-Demellawy, M. A., & Omar, A. M. (2018). Dual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies. Future science OA, 4(1), FSO252. https://doi.org/10.4155/fsoa-2017-0075
El-Miligy, Mostafa Mm, et al. "Dual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies." Future science OA vol. 4,1 (2018): FSO252. doi: https://doi.org/10.4155/fsoa-2017-0075
El-Miligy MM, Rida SM, Ashour FA, Badr MH, El-Bassiony EM, El-Demellawy MA, Omar AM. Dual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies. Future Sci OA. 2017 Oct 25;4(1):FSO252. doi: 10.4155/fsoa-2017-0075. eCollection 2018 Jan. PMID: 29255624; PMCID: PMC5729604.
Copy Download .nbib Format: NLM
Chemotaxonomic Diversity of Three .

Pharmacognosy magazine

Al-Musayeib N, Ebada SS, Gad HA, Youssef FS, Ashour ML.
PMID: 29142422
Pharmacogn Mag. 2017 Oct;13:S613-S622. doi: 10.4103/pm.pm_579_16. Epub 2017 Oct 11.

No abstract available.

Cite
Al-Musayeib N, Ebada SS, Gad HA, et al. Chemotaxonomic Diversity of Three . Pharmacogn Mag. 2017;13:S613-S622doi: 10.4103/pm.pm_579_16.
Al-Musayeib, N., Ebada, S. S., Gad, H. A., Youssef, F. S., & Ashour, M. L. (2017). Chemotaxonomic Diversity of Three . Pharmacognosy magazine, 13S613-S622. https://doi.org/10.4103/pm.pm_579_16
Al-Musayeib, Nawal, et al. "Chemotaxonomic Diversity of Three ." Pharmacognosy magazine vol. 13 (2017): S613-S622. doi: https://doi.org/10.4103/pm.pm_579_16
Al-Musayeib N, Ebada SS, Gad HA, Youssef FS, Ashour ML. Chemotaxonomic Diversity of Three . Pharmacogn Mag. 2017 Oct;13:S613-S622. doi: 10.4103/pm.pm_579_16. Epub 2017 Oct 11. PMID: 29142422; PMCID: PMC5669105.
Copy Download .nbib Format: NLM
Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis.

Global journal of health science

Al-Agha AE, Shaikhain TA, Ashour AA.
PMID: 27045392
Glob J Health Sci. 2016 Aug 01;8(8):48648. doi: 10.5539/gjhs.v8n8p20.

BACKGROUND/AIM: Osteoporosis is a systemic disease characterized by decreased bone density and increased tendency to develop fractures. Osteoporosis in children and adolescents is a rare disease usually secondary to Medical conditions or medications given to children. The condition affects...

Cite
Al-Agha AE, Shaikhain TA, Ashour AA. Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis. Glob J Health Sci. 2016;8(8):48648doi: 10.5539/gjhs.v8n8p20.
Al-Agha, A. E., Shaikhain, T. A., & Ashour, A. A. (2016). Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis. Global journal of health science, 8(8), 48648. https://doi.org/10.5539/gjhs.v8n8p20
Al-Agha, Abdulmoein E, et al. "Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis." Global journal of health science vol. 8,8 (2016): 48648. doi: https://doi.org/10.5539/gjhs.v8n8p20
Al-Agha AE, Shaikhain TA, Ashour AA. Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis. Glob J Health Sci. 2016 Aug 01;8(8):48648. doi: 10.5539/gjhs.v8n8p20. PMID: 27045392; PMCID: PMC5016342.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 248 entries